Vimarsana
Biggest News Aggregation in the World

Page 8 - Communications Materials News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Communications Materials. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Communications Materials Today - Breaking & Trending Today

New N95-like face mask can capture, deactivate Covid spike protein - Vimarsana News

New N95-like face mask can capture, deactivate Covid spike protein

A team of researchers, including one of Indian origin, has developed a medical face mask membrane similar to N95, which can capture and deactivate the SARS-CoV-2 spike protein on contact.SARS-CoV-2 is covered in spike proteins, which allow the ...

UK Researchers Develop Antiviral Face Mask - Vimarsana News

UK Researchers Develop Antiviral Face Mask

A team of faculty and students across campus developed the face mask membrane that can capture and deactivate the SARS-CoV-2 spike protein on contact. The innovation is another layer of protection against COVID-19 that can help prevent the virus from spreading.

Source: uky.edu
Environmental Factor - July 2022: Antiviral membranes boost masks' ability to stop COVID - Vimarsana News

Environmental Factor - July 2022: Antiviral membranes boost masks' ability to stop COVID

Funded by NIEHS and the National Science Foundation, the new membranes capture and deactivate SARS-CoV-2 on contact, preventing the spread of COVID-19.

Source: nih.gov
New Perspective in Nanophotonic Characterization - Vimarsana News

New Perspective in Nanophotonic Characterization

A new non-invasive light mapping technique introduces a new perspective in nanophotonic characterization, ensuring extraordinarily high spatial resolution and accuracy.

Research: Use of new cell delivery method to help cells stick - Vimarsana News

Research: Use of new cell delivery method to help cells stick

According to the findings of research led by the College of Engineering, Carnegie Mellon University, cell-based therapies have long been thought of as an altern